AMG National Trust Bank continued to hold its stake in shares of Digirad Corporation (NASDAQ:DRAD) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 50,842 shares of the medical equipment provider’s stock at the end of the 2nd quarter. AMG National Trust Bank owned about 0.25% of Digirad Corporation worth $206,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of DRAD. Kennedy Capital Management Inc. grew its stake in shares of Digirad Corporation by 37.5% in the second quarter. Kennedy Capital Management Inc. now owns 227,935 shares of the medical equipment provider’s stock valued at $923,000 after buying an additional 62,120 shares in the last quarter. Spark Investment Management LLC grew its stake in Digirad Corporation by 104.7% during the 2nd quarter. Spark Investment Management LLC now owns 82,300 shares of the medical equipment provider’s stock valued at $333,000 after purchasing an additional 42,100 shares in the last quarter. Cadence Capital Management LLC grew its stake in Digirad Corporation by 17.6% during the 1st quarter. Cadence Capital Management LLC now owns 196,120 shares of the medical equipment provider’s stock valued at $1,039,000 after purchasing an additional 29,415 shares in the last quarter. LSV Asset Management acquired a new stake in Digirad Corporation during the 1st quarter valued at approximately $120,000. Finally, ARS Investment Partners LLC grew its stake in Digirad Corporation by 3.4% during the 2nd quarter. ARS Investment Partners LLC now owns 667,026 shares of the medical equipment provider’s stock valued at $2,701,000 after purchasing an additional 22,233 shares in the last quarter. Institutional investors and hedge funds own 53.06% of the company’s stock.
Several analysts recently issued reports on the company. B. Riley reiterated a “buy” rating and set a $6.40 price target on shares of Digirad Corporation in a research report on Monday, July 31st. Zacks Investment Research raised Digirad Corporation from a “sell” rating to a “hold” rating in a research report on Monday, July 3rd.
Digirad Corporation (NASDAQ DRAD) traded up 2.94% during trading on Friday, hitting $3.50. The stock had a trading volume of 1,955 shares. The stock has a 50 day moving average price of $3.72 and a 200 day moving average price of $4.37. The company’s market capitalization is $69.92 million. Digirad Corporation has a 12-month low of $3.40 and a 12-month high of $5.68.
Digirad Corporation (NASDAQ:DRAD) last posted its earnings results on Friday, August 4th. The medical equipment provider reported $0.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.03 by $0.05. The business had revenue of $29.79 million for the quarter, compared to analyst estimates of $30.87 million. Digirad Corporation had a negative net margin of 2.60% and a positive return on equity of 8.58%. Equities research analysts forecast that Digirad Corporation will post $0.17 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, August 30th. Stockholders of record on Friday, August 18th were issued a $0.055 dividend. This is a positive change from Digirad Corporation’s previous quarterly dividend of $0.05. The ex-dividend date was Wednesday, August 16th. This represents a $0.22 dividend on an annualized basis and a dividend yield of 6.38%. Digirad Corporation’s dividend payout ratio is presently -146.66%.
ILLEGAL ACTIVITY NOTICE: This story was first reported by BBNS and is the sole property of of BBNS. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://baseballnewssource.com/markets/digirad-corporation-drad-holdings-maintained-by-amg-national-trust-bank/1601414.html.
Digirad Corporation Company Profile
Digirad Corporation provides healthcare solutions. The Company’s segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center.
Receive News & Ratings for Digirad Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Corporation and related companies with our FREE daily email newsletter.